Published in J Clin Microbiol on February 01, 2005
Viral determinants of resistance to treatment in patients with hepatitis C. Clin Microbiol Rev (2007) 1.65
Genetic diversity of the hepatitis C virus: impact and issues in the antiviral therapy. World J Gastroenterol (2007) 1.22
Hepatitis C virus diversity and evolution in the full open-reading frame during antiviral therapy. PLoS One (2008) 1.02
Impact of hepatitis C virus heterogeneity on interferon sensitivity: an overview. World J Gastroenterol (2014) 0.94
Viral factors influencing the response to the combination therapy of peginterferon plus ribavirin in chronic hepatitis C. J Gastroenterol (2009) 0.91
The evolution of the major hepatitis C genotypes correlates with clinical response to interferon therapy. PLoS One (2009) 0.91
Analysis of mutations within the 5' untranslated region, interferon sensitivity region, and PePHD region as a function of response to interferon therapy in hepatitis C virus-infected patients in India. J Clin Microbiol (2006) 0.86
Quasispecies evolution in NS5A region of hepatitis C virus genotype 1b during interferon or combined interferon-ribavirin therapy. World J Gastroenterol (2007) 0.84
Envelope 2 protein phosphorylation sites S75 & 277 of hepatitis C virus genotype 1a and interferon resistance: a sequence alignment approach. Virol J (2011) 0.80
Analysis of HCV quasispecies dynamic under selective pressure of combined therapy. BMC Infect Dis (2013) 0.77
A novel approach to identify candidate prognostic factors for hepatitis C treatment response integrating clinical and viral genetic data. Evol Bioinform Online (2015) 0.75
Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science (1999) 6.21
Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology (1995) 2.54
Modeling the hepatitis C virus epidemic in France. Hepatology (1999) 1.61
To interfere and to anti-interfere: the interplay between hepatitis C virus and interferon. Viral Immunol (2002) 1.26
Mutations in the E2-PePHD and NS5A region of hepatitis C virus type 1 and the dynamics of hepatitis C viremia decline during interferon alfa treatment. Hepatology (2000) 1.23
Mutations within the E2 and NS5A protein in patients infected with hepatitis C virus type 3a and correlation with treatment response. Hepatology (2000) 1.10
Two PKR inhibitor HCV proteins correlate with early but not sustained response to interferon. Gastroenterology (2000) 1.05
Association of amino acid sequence in the PKR-eIF2 phosphorylation homology domain and response to interferon therapy. Hepatology (2000) 1.03
Mutations in the NS5A and E2-PePHD region of hepatitis C virus type 1b and correlation with the response to combination therapy with interferon and ribavirin. J Viral Hepat (2003) 1.01
Antiviral effect of ribavirin in early non-responders to interferon monotherapy assessed by kinetics of hepatitis C virus RNA and hepatitis C virus core antigen. J Hepatol (2003) 1.00
Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection. J Viral Hepat (2001) 0.98
Sequence analysis of PePHD within HCV E2 region and correlation with resistance of interferon therapy in Japanese patients infected with HCV genotypes 2a and 2b. Am J Gastroenterol (2003) 0.92
Quasispecies heterogeneity of the carboxy-terminal part of the E2 gene including the PePHD and sensitivity of hepatitis C virus 1b isolates to antiviral therapy. Virology (2001) 0.92
Hepatitis C virus: evasion of the interferon-induced antiviral response. J Mol Med (Berl) (2000) 0.90
Influence of the genetic heterogeneity of the ISDR and PePHD regions of hepatitis C virus on the response to interferon therapy in chronic hepatitis C. J Med Virol (2001) 0.89
Variations within hepatitis C virus E2 protein and response to interferon treatment. Virus Res (2001) 0.89
The protein kinase-interacting domain in the hepatitis C virus envelope glycoprotein-2 gene is highly conserved in genotype 1-infected patients treated with interferon. J Infect Dis (2000) 0.85
Mutations in the NS5A and E2-PePHD regions of hepatitis C virus genotype 1b and response to combination therapy of interferon plus ribavirin. Liver Int (2003) 0.85
Amino acid substitutions in PKR-eIF2 phosphorylation homology domain (PePHD) of hepatitis C virus E2 protein in genotype 2a/2b and 1b in Japan and interferon efficacy. Hepatol Res (2003) 0.82
Subtype mutations in the envelope 2 region including phosphorylation homology domain of hepatitis C virus do not predict effectiveness of antiviral therapy. J Viral Hepat (2004) 0.82
Burnout in European family doctors: the EGPRN study. Fam Pract (2008) 2.10
A replication study for association of 53 single nucleotide polymorphisms in ScoliScore test with adolescent idiopathic scoliosis in French-Canadian population. Spine (Phila Pa 1976) (2015) 2.05
Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials. PLoS Med (2012) 1.85
Reproducibility of blood tests of liver fibrosis in clinical practice. Clin Biochem (2007) 1.57
Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection. J Hepatol (2010) 1.51
Genetic features of Pseudomonas aeruginosa isolates from cystic fibrosis patients compared with those of isolates from other origins. J Med Microbiol (2004) 1.32
Endothelin-1 (ET-1) promotes MMP-2 and MMP-9 induction involving the transcription factor NF-kappaB in human osteosarcoma. Clin Sci (Lond) (2006) 1.32
Hepatitis C virus-like particle morphogenesis. J Virol (2002) 1.32
Liver-stage development of Plasmodium falciparum, in a humanized mouse model. J Infect Dis (2006) 1.21
Tetraspanins regulate cell-to-cell transmission of HIV-1. Retrovirology (2009) 1.18
The osteopontin level in liver, adipose tissue and serum is correlated with fibrosis in patients with alcoholic liver disease. PLoS One (2012) 1.17
Novel human reovirus isolated from children with acute necrotizing encephalopathy. Emerg Infect Dis (2011) 1.14
First identification of HIV-1 groups M and O dual infections in Europe. AIDS (2004) 1.12
Therapeutic potential of nanoparticulate systems for macrophage targeting. Biomaterials (2005) 1.11
Genetic heterogeneity of the NS3 protease gene in hepatitis C virus genotype 1 from untreated infected patients. J Med Virol (2005) 1.08
Subtype B human immunodeficiency virus (HIV) type 1 mutant that escapes detection in a fourth-generation immunoassay for HIV infection. J Clin Microbiol (2004) 1.07
Fasting energy homeostasis in mice with adipose deficiency of desnutrin/adipose triglyceride lipase. Endocrinology (2012) 1.07
Human immunodeficiency virus serotyping on dried serum spots as a screening tool for the surveillance of the AIDS epidemic. J Med Virol (2006) 1.07
Clustering and mobility of HIV-1 Env at viral assembly sites predict its propensity to induce cell-cell fusion. J Virol (2013) 1.06
Molecular determinants of melatonin signaling dysfunction in adolescent idiopathic scoliosis. Clin Orthop Relat Res (2007) 1.06
Human papillomavirus quantification in urine and cervical samples by using the Mx4000 and LightCycler general real-time PCR systems. J Clin Microbiol (2007) 1.05
The genetic epidemiology of idiopathic scoliosis. Eur Spine J (2012) 1.02
High burden of non-influenza viruses in influenza-like illness in the early weeks of H1N1v epidemic in France. PLoS One (2011) 1.01
Clinical and cellular manifestations of OSTM1-related infantile osteopetrosis. J Bone Miner Res (2008) 1.01
Antiviral effect of ribavirin in early non-responders to interferon monotherapy assessed by kinetics of hepatitis C virus RNA and hepatitis C virus core antigen. J Hepatol (2003) 1.00
Group o human immunodeficiency virus type 1 infection that escaped detection in two immmunoassays. J Clin Microbiol (2006) 1.00
Evolutionary dynamics of the glycan shield of the human immunodeficiency virus envelope during natural infection and implications for exposure of the 2G12 epitope. J Virol (2004) 0.99
Maternal neutralizing antibodies against a CRF01_AE primary isolate are associated with a low rate of intrapartum HIV-1 transmission. Virology (2009) 0.98
Hepatitis C virus-like particle budding: role of the core protein and importance of its Asp111. J Virol (2003) 0.98
Usefulness of the hepatitis C virus core antigen assay for screening of a population undergoing routine medical checkup. J Clin Microbiol (2005) 0.98
Fatal algaemia in patient with chronic lymphocytic leukemia. Emerg Infect Dis (2009) 0.96
Prevalence, risk factors, and molecular epidemiology of hepatitis B and hepatitis delta virus in pregnant women and in patients in Mauritania. J Med Virol (2012) 0.96
Perinatal maternal fat intake affects metabolism and hippocampal function in the offspring: a potential role for leptin. Ann N Y Acad Sci (2008) 0.95
Estrogen cross-talk with the melatonin signaling pathway in human osteoblasts derived from adolescent idiopathic scoliosis patients. J Pineal Res (2008) 0.95
Characteristics of HIV type 1 (HIV-1) glycoprotein 120 env sequences in mother-infant pairs infected with HIV-1 subtype CRF01_AE. J Infect Dis (2008) 0.94
Biochemistry of adolescent idiopathic scoliosis. Adv Clin Chem (2011) 0.93
Prevalence, risk factors, and impact of isolated antibody to hepatitis B core antigen and occult hepatitis B virus infection in HIV-1-infected pregnant women. Clin Infect Dis (2013) 0.92
A novel fusionless vertebral physeal device inducing spinal growth modulation for the correction of spinal deformities. Eur Spine J (2008) 0.90
Muscle-bone characteristics in children with Prader-Willi syndrome. J Clin Endocrinol Metab (2011) 0.89
CFTR depletion results in changes in fatty acid composition and promotes lipogenesis in intestinal Caco 2/15 cells. PLoS One (2010) 0.89
Impact of hepatitis B and delta virus co-infection on liver disease in Mauritania: a cross sectional study. J Infect (2013) 0.88
Cell-based screening test for idiopathic scoliosis using cellular dielectric spectroscopy. Spine (Phila Pa 1976) (2010) 0.86
CFTR knockdown stimulates lipid synthesis and transport in intestinal Caco-2/15 cells. Am J Physiol Gastrointest Liver Physiol (2009) 0.86
New emerging role of pitx1 transcription factor in osteoarthritis pathogenesis. Clin Orthop Relat Res (2007) 0.85
Naturally occurring substitutions of conserved residues in human immunodeficiency virus type 1 variants of different clades are involved in PG9 and PG16 resistance to neutralization. J Gen Virol (2012) 0.85
[Quality of life assessment of type 2 diabetic patients in general medicine]. Presse Med (2004) 0.85
Sequence and functional analysis of the envelope glycoproteins of hepatitis C virus variants selectively transmitted to a new host. J Virol (2013) 0.84
[Autochthonous hepatitis E in France and consumption of raw pig meat]. Gastroenterol Clin Biol (2007) 0.84
Sustained virologic response with ribavirin in chronic hepatitis E virus infection in heart transplantation. J Heart Lung Transplant (2011) 0.84
Ablation of osteopontin improves the skeletal phenotype of phospho1(-/-) mice. J Bone Miner Res (2014) 0.84
Evidence for a continuous drift of the HIV-1 species towards higher resistance to neutralizing antibodies over the course of the epidemic. PLoS Pathog (2013) 0.83
Viral sequence variation in chronic carriers of hepatitis C virus has a low impact on liver steatosis. PLoS One (2012) 0.83
Abnormal Skeletal Growth in Adolescent Idiopathic Scoliosis Is Associated with Abnormal Quantitative Expression of Melatonin Receptor, MT2. Int J Mol Sci (2013) 0.83
[Musculoskeletal chronic pains and Vitamin D deficiency. Study before after in general practice]. Presse Med (2013) 0.83
Significance of pretreatment analysis of hepatitis C virus genotype 1b hypervariable region 1 sequences to predict antiviral outcome. J Clin Microbiol (2003) 0.82
Nuclear accumulation of prohibitin 1 in osteoarthritic chondrocytes down-regulates PITX1 expression. Arthritis Rheum (2013) 0.82
Campylobacter fetus subspecies fetus spondylodiscitis. J Med Microbiol (2010) 0.82
Spinal growth modulation using a novel intravertebral epiphyseal device in an immature porcine model. Eur Spine J (2011) 0.82
[Etiopathogenesis of adolescent idiopathic scoliosis and new molecular concepts]. Med Sci (Paris) (2007) 0.81
Use of an anti-hepatitis C virus (HCV) IgG avidity assay to identify recent HCV infection. J Clin Microbiol (2010) 0.81
The role of spinal concave-convex biases in the progression of idiopathic scoliosis. Eur Spine J (2009) 0.81
Long-term hepatitis B virus (HBV) response to lamivudine-containing highly active antiretroviral therapy in HIV-HBV co-infected patients in Thailand. PLoS One (2012) 0.81
The metabolic basis of adolescent idiopathic scoliosis: 2011 report of the "metabolic" workgroup of the Fondation Yves Cotrel. Eur Spine J (2012) 0.80
Association between a polymorphism in the human programmed death-1 (PD-1) gene and cytomegalovirus infection after kidney transplantation. J Med Genet (2009) 0.80
Continuous spread of HIV-1 subtypes D and CRF01_AE in France from 2003 to 2009. J Clin Microbiol (2012) 0.80
Human platelet Ca2+-ATPases: new markers of cell differentiation as illustrated in idiopathic scoliosis. Platelets (2006) 0.80
Human immunodeficiency virus type-1 (HIV-1) continues to evolve in presence of broadly neutralizing antibodies more than ten years after infection. PLoS One (2012) 0.80
Rapid and sustained autologous neutralizing response leading to early spontaneous recovery after HCV infection. Virology (2013) 0.79
Association between a polymorphism in the IL-12p40 gene and cytomegalovirus reactivation after kidney transplantation. Transplantation (2008) 0.79
Biomechanical simulations of the scoliotic deformation process in the pinealectomized chicken: a preliminary study. Scoliosis (2007) 0.78
Biomechanical comparison of fusionless growth modulation corrective techniques in pediatric scoliosis. Med Biol Eng Comput (2011) 0.78
Novel Hemi-Staple for the Fusionless Correction of Pediatric Scoliosis: Influence on Intervertebral Disks and Growth Plates in a Porcine Model. Clin Spine Surg (2016) 0.78
The International Research Society of Spinal Deformities (IRSSD) and its contribution to science. Scoliosis (2009) 0.77
Cell-based assay protocol for the prognostic prediction of idiopathic scoliosis using cellular dielectric spectroscopy. J Vis Exp (2013) 0.77
Xylem anatomy correlates with gas exchange, water-use efficiency and growth performance under contrasting water regimes: evidence from Populus deltoides x Populus nigra hybrids. Tree Physiol (2009) 0.77
Analysis of residual perinatal transmission of hepatitis B virus (HBV) and of genetic variants in human immunodeficiency virus and HBV co-infected women and their offspring. J Clin Virol (2013) 0.77
Case report: benefits of quantitative polymerase chain reaction in the clinical management of herpes simplex virus 1 infection with prominent hepatitis and unusual secondary progression. J Med Virol (2012) 0.77
PTHrP(1-34)-mediated repression of the PHEX gene in osteoblastic cells involves the transcriptional repressor E4BP4. J Cell Physiol (2012) 0.76
[The difficulty of measurement of placebo effect]. Therapie (2006) 0.76
HIV surveillance combining an assay for identification of very recent infection and phylogenetic analyses on dried spots. AIDS (2016) 0.76
V1/V2 Neutralizing Epitope is Conserved in Divergent Non-M Groups of HIV-1. J Acquir Immune Defic Syndr (2016) 0.75
Correlates of quality of life of pre-obese and obese patients: a pharmacy-based cross-sectional survey. BMC Public Health (2009) 0.75
Congenital Trypanosomiasis in Child Born in France to African Mother. Emerg Infect Dis (2016) 0.75
Is there excess mortality in women screened with mammography: a meta-analysis of non-breast cancer mortality. Trials (2013) 0.75
Emergence of blaNDM-7-Producing Enterobacteriaceae in Gabon, 2016. Emerg Infect Dis (2017) 0.75
Interest of simultaneous Chlamydia trachomatis and Neisseria gonorrhoeae screening at the time of preabortion consultation. Contraception (2012) 0.75
[Tuberculosis -HIV, a common and sensitive care in connection with a case of pleural tuberculosis revealing AIDS]. Ann Biol Clin (Paris) (2011) 0.75
Treatment of chronic hepatitis C in patients unresponsive to interferon. Interest of re-treatment combining interferon induction therapy and ribavirin (a multicenter pilot study). Gastroenterol Clin Biol (2005) 0.75
Heteroleptic bis(cis-1,2-disubstituted ethylene-1,2-dithiolato)nickel complexes obtained by ligand-exchange reaction: synthesis and properties. Inorg Chem (2014) 0.75
A Replication Study for Association of LBX1 locus with Adolescent Idiopathic Scoliosis in French-Canadian Population. Spine (Phila Pa 1976) (2017) 0.75
Air contamination around patients colonized with multidrug-resistant organisms. Infect Control Hosp Epidemiol (2012) 0.75